Open AccessEight Years of Growth Hormone Treatment in Children With Prader-Willi Syndrome: Maintaining the Positive Effects
Author(s) -
Nienke Bakker,
Renske Kuppens,
Elbrich P. C. Siemensma,
Roderick F. A. Tummers-de Lind van Wijngaarden,
Dederieke A. M. Festen,
G. C. B. Bindels-de Heus,
Gianni Bocca,
Danny A. J. P. Haring,
J. J. Gera Hoorweg-Nijman,
E. C. A. M. Houdijk,
Petr Jira,
L. Lunshof,
Roelof J. Odink,
Wilma Oostdijk,
Joost Rotteveel,
Eelco J. Schroor,
A. A. E. M. Van Alfen,
Mariëtte van Leeuwen,
Evelyn van Pinxteren-Nagler,
Hester van Wieringen,
René C. F. M. Vreuls,
Nitash ZwavelingSoonawala,
Maria de Ridder,
Anita C. S. HokkenKoelega
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2013-2012
Subject(s) - medicine , body mass index , lean body mass , endocrinology , obesity , prospective cohort study , cohort , growth hormone treatment , hormone , body weight , growth hormone
The most important reason for treating children with Prader-Willi syndrome (PWS) with GH is to optimize their body composition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom